Current status of treatment of spinal and bulbar muscular atrophy

Neural Plasticity

Volumn 2012, Issue , 2012, Pages

  Tanaka, Fumiaki ^a   Katsuno, Masahisa ^a   Banno, Haruhiko ^a   Suzuki, Keisuke ^a   Adachi, Hiroaki ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALVESPIMYCIN; ANDROGEN RECEPTOR; ASC J9; BUTYRIC ACID; CURCUMIN; DUTASTERIDE; DYNACTIN; IDEBENONE; LEUPRORELIN; PLACEBO; PROTEASOME; RAPAMYCIN; TEPRENONE; TRANSFORMING GROWTH FACTOR BETA; TREHALOSE; UBIDECARENONE; UBIQUITIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ANTIANDROGEN; HORMONE ANTAGONIST; LIGAND;

AMINO TERMINAL SEQUENCE; ANDROGEN DEPRIVATION THERAPY; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; ENDOMETRIOSIS; GENE TRANSLOCATION; HUMAN; KENNEDY DISEASE; NONHUMAN; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; GENE THERAPY; GENETICS; METABOLISM; METHODOLOGY; TREATMENT OUTCOME;

ANDROGEN ANTAGONISTS; ANIMALS; BULBO-SPINAL ATROPHY, X-LINKED; GENETIC THERAPY; HORMONE ANTAGONISTS; HUMANS; LIGANDS; RECEPTORS, ANDROGEN; TREATMENT OUTCOME;

EID: 84863738736     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2012/369284     Document Type: Review

References (80)

1. Kawahara H., A family of progressive bulbar palsy Aichi Medical Journal 1897 16 3 4
2. Kennedy W. R., Alter M., Sung J. H., Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait Neurology 1968 18 7 671 680
3. Parodi S., Pennuto M., Neurotoxic effects of androgens in spinal and bulbar muscular atrophy Frontiers in Neuroendocrinology 2011 32 4 416 425
4. Katsuno M., Adachi H., Waza M., Banno H., Suzuki K., Tanaka F., Doyu M., Sobue G., Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA) Experimental Neurology 2006 200 1 8 18 (Pubitemid 44080751)
5. La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H., Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy Nature 1991 352 6330 77 79 (Pubitemid 21896702)
6. Tanaka F., Doyu M., Ito Y., Matsumoto M., Mitsuma T., Abe K., Aoki M., Itoyama Y., Fischbeck K. H., Sobue G., Founder effect in spinal and bulbar muscular atrophy (SBMA) Human Molecular Genetics 1996 5 9 1253 1257 (Pubitemid 26335842)
7. Li M., Miwa S., Kobayashi Y., Merry D. E., Yamamoto M., Tanaka F., Doyu M., Hashizume Y., Fischbeck K. H., Sobue G., Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy Annals of Neurology 1998 44 2 249 254 (Pubitemid 28374114)
8. Finsterer J., Perspectives of Kennedy's disease Journal of the Neurological Sciences 2010 298 1-2 1 10
9. Zoghbi H. Y., Orr H. T., Glutamine repeats and neurodegeneration Annual Review of Neuroscience 2000 23 217 247 (Pubitemid 30350043)
10. Orr H. T., Zoghbi H. Y., Trinucleotide repeat disorders Annual Review of Neuroscience 2007 30 575 621 (Pubitemid 47218768)
11. Tanaka F., Sobue G., Doyu M., Ito Y., Yamamoto M., Shimada N., Yamamoto K., Riku S., Hshizume Y., Mitsuma T., Differential pattern in tissue-specific somatic mosaicism of expanded CAG trinucleotide repeat in dentatorubral- pallidoluysian atrophy, Machado-Joseph disease, and X-linked recessive spinal and bulbar muscular atrophy Journal of the Neurological Sciences 1996 135 1 43 50
12. Tanaka F., Reeves M. F., Ito Y., Matsumoto M., Li M., Miwa S., Inukai A., Yamamoto M., Doyu M., Yoshida M., Hashizume Y., Terao S. I., Mitsuma T., Sobue G., Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptorgene expression level American Journal of Human Genetics 1999 65 4 966 973 (Pubitemid 30462953)
13. Yamada M., Sato T., Tsuji S., Takahashi H., CAG repeat disorder models and human neuropathology: similarities and differences Acta Neuropathologica 2008 115 1 71 86 (Pubitemid 350238668)
14. Perutz M. F., Johnson T., Suzuki M., Finch J. T., Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases Proceedings of the National Academy of Sciences of the United States of America 1994 91 12 5355 5358 (Pubitemid 24174325)
15. Taylor J. P., Tanaka F., Robitschek J., Sandoval C. M., Taye A., Markovic-Plese S., Fischbeck K. H., Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein Human Molecular Genetics 2003 12 7 749 757 (Pubitemid 36416961)
16. Arrasate M., Mitra S., Schweitzer E. S., Segal M. R., Finkbeiner S., Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 2004 431 7010 805 810 (Pubitemid 39434070)
17. Palazzolo I., Nedelsky N. B., Askew C. E., Harmison G. G., Kasantsev A. G., Taylor J. P., Fischbeck K. H., Pennuto M., B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy Journal of Neuroscience Research 2010 88 10 2207 2216
18. Adachi H., Katsuno M., Minamiyama M., Waza M., Sang C., Nakagomi Y., Kobayashi Y., Tanaka F., Doyu M., Inukai A., Yoshida M., Hashizume Y., Sobue G., Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients Brain 2005 128 3 659 670 (Pubitemid 40380200)
19. Adachi H., Waza M., Tokui K., Katsuno M., Minamiyama M., Tanaka F., Doyu M., Sobue G., CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model Journal of Neuroscience 2007 27 19 5115 5126 (Pubitemid 46741791)
20. Nedelsky N. B., Pennuto M., Smith R. B., Palazzolo I., Moore J., Nie Z., Neale G., Taylor J. P., Native functions of the androgen receptor are essential to pathogenesis in a drosophila model of spinobulbar muscular atrophy Neuron 2010 67 6 936 952
21. Monks D. A., Johansen J. A., Mo K., Rao P., Eagleson B., Yu Z., Lieberman A. P., Breedlove S. M., Jordan C. L., Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 46 18259 18264 (Pubitemid 350210854)
22. Katsuno M., Banno H., Suzuki K., Adachi H., Tanaka F., Sobue G., Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy Archives of Neurology 2012 69 4 436 440
23. Rusmini P., Bolzoni E., Crippa V., Onesto E., Sau D., Galbiati M., Piccolella M., Poletti A., Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy Neurobiology of Disease 2010 40 2 361 369
24. Orr C. R., Montie H. L., Liu Y., Bolzoni E., Jenkins S. C., Wilson E. M., Joseph J. D., McDonnell D. P., Merry D. E., An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy Journal of Biological Chemistry 2010 285 46 35567 35577
25. Mhatre A. N., Trifiro M. A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., Pinsky L., Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy Nature Genetics 1993 5 2 184 188 (Pubitemid 23293456)
26. Kazemi-Esfarjani P., Trifiro M. A., Pinsky L., Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG) n-expanded neuronopathies Human Molecular Genetics 1995 4 4 523 527
27. Dejager S., Bry-Gauillard H., Bruckert E., Eymard B., Salachas F., LeGuern E., Tardieu S., Chadarevian R., Giral P., Turpin G., A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length Journal of Clinical Endocrinology and Metabolism 2002 87 8 3893 3901 (Pubitemid 34879545)
28. Brinkmann A. O., Molecular basis of androgen insensitivity Molecular and Cellular Endocrinology 2001 179 1-2 105 109 (Pubitemid 32564957)
29. Sato T., Matsumoto T., Yamada T., Watanabe T., Kawano H., Kato S., Late onset of obesity in male androgen receptor-deficient (AR KO) mice Biochemical and Biophysical Research Communications 2003 300 1 167 171 (Pubitemid 36042946)
30. Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., Sobue G., Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Neuron 2002 35 5 843 854
31. Takeyama K. I., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., Kato S., Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila Neuron 2002 35 5 855 864
32. Chevalier-Larsen E. S., O'Brien C. J., Wang H., Jenkins S. C., Holder L., Lieberman A. P., Merry D. E., Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy Journal of Neuroscience 2004 24 20 4778 4786 (Pubitemid 38668202)
33. Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D. M., Lieberman A. P., Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model Journal of Clinical Investigation 2006 116 10 2663 2672 (Pubitemid 44511630)
34. Montie H. I., Cho M. S., Holder L., Liu Y., Tsvetkov A. S., Finkbeiner S., Merry D. E., Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy Human Molecular Genetics 2009 18 11 1937 1950
35. Katsuno M., Adachi H., Doyu M., Minamiyama M., Sang C., Kobayashi Y., Inukai A., Sobue G., Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy Nature Medicine 2003 9 6 768 773 (Pubitemid 36749228)
36. Banno H., Katsurio M., Suzuki K., Takeuchi Y., Kawashima M., Suga N., Takamori M., Ito M., Nakamura T., Matsuo K., Yamada S., Oki Y., Adachi H., Minamiyama M., Waza M., Atsnra N., Watanabe H., Fujimoto Y., Nakashima T., Tanaka F., Doyu M., Sobue G., Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy Annals of Neurology 2009 65 2 140 150
37. Katsuno M., Banno H., Suzuki K., Takeuchi Y., Kawashima M., Yabe I., Sasaki H., Aoki M., Morita M., Nakano I., Kanai K., Ito S., Ishikawa K., Mizusawa H., Yamamoto T., Tsuji S., Hasegawa K., Shimohata T., Nishizawa M., Miyajima H., Kanda F., Watanabe Y., Nakashima K., Tsujino A., Yamashita T., Uchino M., Fujimoto Y., Tanaka F., Sobue G., Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial The Lancet Neurology 2010 9 9 875 884
38. Fernndez-Rhodes L. E., Kokkinis A. D., White M. J., Watts C. A., Auh S., Jeffries N. O., Shrader J. A., Lehky T. J., Li L., Ryder J. E., Levy E. W., Solomon B. I., Harris-Love M. O., La Pean A., Schindler A. B., Chen C., Di Prospero N. A., Fischbeck K. H., Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial The Lancet Neurology 2011 10 2 140 147
39. Shimohata T., Kimura T., Nishizawa M., Onodera O., Tsuji S., Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin Journal of Neurology, Neurosurgery and Psychiatry 2004 75 8 1206 1207 (Pubitemid 39005794)
40. Palazzolo I., Burnett B. G., Young J. E., Brenne P. L., La Spada A. R., Fischbeck K. H., Howell B. W., Pennuto M., Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity Human Molecular Genetics 2007 16 13 1593 1603 (Pubitemid 47050673)
41. Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J. P., Sumner C. J., Fischbeck K. H., Pennuto M., Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy Neuron 2009 63 3 316 328
42. He B., Kemppainen J. A., Voegel J. J., Gronemeyer H., Wilson E. M., Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH 2 -terminal domain Journal of Biological Chemistry 1999 274 52 37219 37225
43. Schaufele F., Carbonell X., Guerbadot M., Borngraeber S., Chapman M. S., Ma A. A. K., Miner J. N., Diamond M. I., The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions Proceedings of the National Academy of Sciences of the United States of America 2005 102 28 9802 9807 (Pubitemid 40993649)
44. He B., Gampe R. T., Kole A. J., Hnat A. T., Stanley T. B., An G., Stewart E. L., Kalman R. I., Minges J. T., Wilson E. M., Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance Molecular Cell 2004 16 3 425 438 (Pubitemid 39504796)
45. Orr C. R., Montie H. L., Liu Y., Bolzoni E., Jenkins S. C., Wilson E. M., Joseph J. D., McDonnell D. P., Merry D. E., An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy Journal of Biological Chemistry 2010 285 46 35567 35577
46. Jochum T., Ritz M. E., Schuster C., Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures Biochimica et Biophysica Acta 2012 1822 6 1070 1078
47. Heinlein C. A., Chang C., Androgen receptor (AR) coregulators: an overview Endocrine Reviews 2002 23 2 175 200 (Pubitemid 34299023)
48. Van Royen M. E., Cunha S. M., Brink M. C., Mattern K. A., Nigg A. L., Dubbink H. J., Verschure P. J., Trapman J., Houtsmuller A. B., Compartmentalization of androgen receptor protein-protein interactions in living cells Journal of Cell Biology 2007 177 1 63 72 (Pubitemid 46588402)
49. McCampbell A., Fischbeck K. H., Polyglutamine and CBP: fatal attraction? Nature Medicine 2001 7 5 528 530 (Pubitemid 32448308)
50. McCampbell A., Taylor J. P., Taye A. A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., Fischbeck K. H., CREB-binding protein sequestration by expanded polyglutamine Human Molecular Genetics 2000 9 14 2197 2202
51. Yang Z., Chang Y. J., Yu I. C., Yeh S., Wu C. C., Miyamoto H., Merry D. E., Sobue G., Chen L. M., Chang S. S., Chang C., ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor Nature Medicine 2007 13 3 348 353 (Pubitemid 46376683)
52. Taylor J. P., Taye A. A., Campbell C., Kazemi-Esfarjani P., Fischbeck K. H., Min K. T., Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein Genes and Development 2003 17 12 1463 1468 (Pubitemid 36734703)
53. Minamiyama M., Katsuno M., Adachi H., Waza M., Sang C., Kobayashi Y., Tanaka F., Doyu M., Inukai A., Sobue G., Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Human Molecular Genetics 2004 13 11 1183 1192 (Pubitemid 38787000)
54. Sopher B. L., Thomas P. S., Lafevre-Bernt M. A., Holm I. E., Wilke S. A., Ware C. B., Jin L. W., Libby R. T., Ellerby L. M., La Spada A. R., Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration Neuron 2004 41 5 687 699 (Pubitemid 38326832)
55. Katsuno M., Sobue G., Polyglutamine diminishes VEGF: passage to motor neuron death? Neuron 2004 41 5 677 679 (Pubitemid 38326828)
56. Katsuno M., Adachi H., Minamiyama M., Waza M., Tokui K., Banno H., Suzuki K., Onoda Y., Tanaka F., Doyu M., Sobue G., Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration Journal of Neuroscience 2006 26 47 12106 12117 (Pubitemid 44808377)
57. Katsuno M., Adachi H., Minamiyama M., Waza M., Doi H., Kondo N., Mizoguchi H., Nitta A., Yamada K., Banno H., Suzuki K., Tanaka F., Sobue G., Disrupted transforming growth factor- signaling in spinal and bulbar muscular atrophy Journal of Neuroscience 2010 30 16 5702 5712
58. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Dorpe J. V., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Bosch L. V. D., Cashman N., Fujisawa H., Drost M. R., Sciot R., Bruyninckx F., Hicklin D. J., Ince C., Gressens P., Lupu F., Plate K. H., Robberecht W., Herbert J. M., Collen D., Carmeliet P., Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Nature Genetics 2001 28 2 131 138 (Pubitemid 32538057)
59. Gill S. R., Schroer T. A., Szilak I., Steuer E. R., Sheetz M. P., Cleveland D. W., Dynactin, a conserved, ubiquitously expressed component of an activator of vesicle motility mediated by cytoplasmic dynein Journal of Cell Biology 1991 115 6 1639 1650 (Pubitemid 21910004)
60. Hirokawa N., Niwa S., Tanaka Y., Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease Neuron 2010 68 4 610 638
61. Puls I., Jonnakuty C., LaMonte B. H., Holzbaur E. L. F., Tokito M., Mann E., Floeter M. K., Bidus K., Drayna D., Oh S. J., Brown R. H., Ludlow C. L., Fischbeck K. H., Mutant dynactin in motor neuron disease Nature Genetics 2003 33 4 455 456 (Pubitemid 36390002)
62. Flanders K. C., Ren R. F., Lippa C. F., Transforming growth factor- S in neurodegenerative disease Progress in Neurobiology 1998 54 1 71 85 (Pubitemid 28049820)
63. Kobayashi Y., Kume A., Li M., Doyu M., Hata M., Ohtsuka K., Sobue G., Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract Journal of Biological Chemistry 2000 275 12 8772 8778 (Pubitemid 30180231)
64. Bailey C. K., Andriola I. F. M., Kampinga H. H., Merry D. E., Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy Human Molecular Genetics 2002 11 5 515 523 (Pubitemid 34257488)
65. Adachi H., Katsuno M., Minamiyama M., Sang C., Pagoulatos G., Angelidis C., Kusakabe M., Yoshiki A., Kobayashi Y., Doyu M., Sobue G., Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein Journal of Neuroscience 2003 23 6 2203 2211 (Pubitemid 36368908)
66. Morishima Y., Wang A. M., Yu Z., Pratt W. B., Osawa Y., Lieberman A. P., CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins Human Molecular Genetics 2008 17 24 3942 3952 (Pubitemid 352762855)
67. Katsuno M., Sang C., Adachi H., Minamiyama M., Waza M., Tanaka F., Doyu M., Sobue G., Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease Proceedings of the National Academy of Sciences of the United States of America 2005 102 46 16801 16806 (Pubitemid 41688857)
68. Waza M., Adachi H., Katsuno M., Minamiyama M., Sang C., Tanaka F., Inukai A., Doyu M., Sobue G., 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration Nature Medicine 2005 11 10 1088 1095 (Pubitemid 41486831)
69. Waza M., Adachi H., Katsuno M., Minamiyama M., Tanaka F., Doyu M., Sobue G., Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein Journal of Molecular Medicine 2006 84 8 635 646 (Pubitemid 44162553)
70. Tokui K., Adachi H., Waza M., Katsuno M., Minamiyama M., Doi H., Tanaka K., Hamazaki J., Murata S., Tanaka F., Sobue G., 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse Human Molecular Genetics 2009 18 5 898 910
71. Goetz M. P., Toft D. O., Ames M. M., Erlichman C., The Hsp90 chaperone complex as a novel target for cancer therapy Annals of Oncology 2003 14 8 1169 1176 (Pubitemid 37039035)
72. Rusmini P., Simonini F., Crippa V., Bolzoni E., Onesto E., Cagnin M., Sau D., Ferri N., Poletti A., 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy Neurobiology of Disease 2011 41 1 83 95
73. Pandey U. B., Nie Z., Batlevi Y., McCray B. A., Ritson G. P., Nedelsky N. B., Schwartz S. L., Diprospero N. A., Knight M. A., Schuldiner O., Padmanabhan R., Hild M., Berry D. L., Garza D., Hubbert C. C., Yao T. P., Baehrecke E. H., Taylor J. P., HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS Nature 2007 447 7146 859 863 (Pubitemid 46920134)
74. Montie H. L., Merry D. E., Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA Autophagy 2009 5 8 1194 1197
75. Yu Z., Wang A. M., Adachi H., Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice PLoS Genetics 2011 7 10
76. Di Prospero N. A., Fischbeck K. H., Therapeutics development for triplet repeat expansion diseases Nature Reviews Genetics 2005 6 10 756 765 (Pubitemid 41400833)
77. Trushina E., McMurray C. T., Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases Neuroscience 2007 145 4 1233 1248 (Pubitemid 46602738)
78. Ranganathan S., Harmison G. G., Meyertholen K., Pennuto M., Burnett B. G., Fischbeck K. H., Mitochondrial abnormalities in spinal and bulbar muscular atrophy Human Molecular Genetics 2009 18 1 27 42
79. Banno H., Katsuno M., Suzuki K., Sobue G., Dutasteride for spinal and bulbar muscular atrophy The Lancet Neurology 2011 10 2 113 115
80. Hashizume A., Katsuno M., Banno H., Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy Journal of Neurology 2012 259 4 712 719